Implanet has been definitively granted intellectual protection for its JAZZ technology in Europe until 2031 (patent number EP 2521500).
The patent applies to the entire JAZZ system and definitively secures full protection of the implant’s technical characteristics. Jazz is a temporary implant to be used in orthopaedic surgery and is a bony anchor designed to guarantee temporary stabilisation for bony fusion or for consolidation of a fracture. The system is designed primarily for a posterior fixation.
Ludovic Lastennet, chief executive officer of Implanet, said: “We can now capitalise on this patent to accelerate JAZZ’s transformation into a technological platform comprising a comprehensive range of implants covering 100% of our market. Our highly-promising portfolio of innovations will enable us to rapidly meet the demands of the entire spine surgeon community.”